In addition, one study showed an increasing trend in prescribing of RAAS inhibitors and statins in secondary CKD patients. 5 Not much is known about differences in prescribing quality in CKD patients between healthcare organisations.
← all excerpts
Prescribing quality in secondary care patients with different stages of chronic kidney disease: a retrospective study in the Netherlands.
1
—
—